Khazanah Nasional’s partial takeover offer for Parkway Holdings (P27.SG) may throw spotlight on other Singapore healthcare companies with strong track record, says DMG, according to Dow Jones.

DMG notes while the move is unlikely to raise M&A hopes for other healthcare groups like Raffles Medical (R01.SG), Thomson Medical (5FV.SG) and Healthway Medical (5NG.SG), growth prospects for sector remain strong as these are primarily Singapore-focused players.

The research house notes Raffles Medical continues to record growth each quarter, even during last year’s economic downturn: “This reflects Raffles Medical’s ability to position itself as a destination for foreign patients, with its focus on curative healthcare services.”

Rates Parkway, Raffles Medical, Thomson Medical, Healthway at Buy with respective target price of $3.36, $1.86, $0.78, $0.30.

FTSE ST Healthcare Index +14.5%.